Skip to Content
Merck
All Photos(2)

Key Documents

View All Documentation

GF96781214

Beryllium

wire reel, 0.1m, diameter 0.6mm, annealed and clean, 99%

Synonym(s):

Beryllium, BE005126, Glucinium

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Empirical Formula (Hill Notation):
Be
CAS Number:
7440-41-7
Molecular Weight:
9.01
MDL number:
MFCD00134032
UNSPSC Code:
12141501
PubChem Substance ID:
329814595
NACRES:
NA.23

Assay

≥99%

form

wire

autoignition temp.

1198 °F

manufacturer/tradename

Goodfellow 967-812-14

resistivity

4.46 μΩ-cm, 20°C

bp

2970 °C (lit.)

mp

1278 °C (lit.)

density

1.85 g/mL at 25 °C (lit.)

SMILES string

[Be]

InChI

1S/Be

InChI key

ATBAMAFKBVZNFJ-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

For updated SDS information please visit www.goodfellow.com.

Legal Information

Product of Goodfellow

Pictograms

Skull and crossbonesHealth hazard
GHS06,GHS08

Signal Word

Danger

Hazard Classifications

Acute Tox. 3 Oral - Carc. 1B - Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT RE 1

Storage Class Code

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

John R Balmes et al.
American journal of respiratory and critical care medicine, 190(10), e34-e59 (2014-11-15)
Beryllium continues to have a wide range of industrial applications. Exposure to beryllium can lead to sensitization (BeS) and chronic beryllium disease (CBD). The purpose of this statement is to increase awareness and knowledge about beryllium exposure, BeS, and CBD.
Linus H Santo Tomas
Current opinion in pulmonary medicine, 15(2), 165-169 (2009-06-18)
This review aims to present the clinician with a synthesis of recent studies that have enhanced our understanding of the epidemiology and pathogenesis of beryllium hypersensitivity (BeH) and chronic beryllium disease (CBD). Lower occupational limit levels to beryllium exposure and
Michael J Brisson et al.
Journal of environmental monitoring : JEM, 8(6), 605-611 (2006-06-13)
Control of workplace exposure to beryllium is a growing issue in the United States and other nations. As the health risks associated with low-level exposure to beryllium are better understood, the need increases for improved analytical techniques both in the
Elijah Thimsen et al.
Nature communications, 5, 5822-5822 (2014-12-20)
Thin films comprising semiconductor nanocrystals are emerging for applications in electronic and optoelectronic devices including light emitting diodes and solar cells. Achieving high charge carrier mobility in these films requires the identification and elimination of electronic traps on the nanocrystal
D M Hollins et al.
Critical reviews in toxicology, 39 Suppl 1, 1-32 (2009-11-13)
The potential carcinogenicity of beryllium has been a topic of study since the mid-1940s. Since then, numerous scientific and regulatory bodies have assigned beryllium to various categories with respect to its carcinogenicity. Past epidemiologic and animal studies, however, have been
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service